S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   123.03 (+0.25%)
MSFT   214.08 (-0.99%)
FB   288.02 (+0.51%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,209.37 (-0.33%)
TSLA   561.14 (-4.04%)
NVDA   542.20 (+1.23%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.43 (+2.01%)
AMD   93.86 (+1.33%)
T   28.94 (+0.24%)
NIO   46.52 (+2.56%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.75 (-0.36%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.42 (+1.99%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   123.03 (+0.25%)
MSFT   214.08 (-0.99%)
FB   288.02 (+0.51%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,209.37 (-0.33%)
TSLA   561.14 (-4.04%)
NVDA   542.20 (+1.23%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.43 (+2.01%)
AMD   93.86 (+1.33%)
T   28.94 (+0.24%)
NIO   46.52 (+2.56%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.75 (-0.36%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.42 (+1.99%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   123.03 (+0.25%)
MSFT   214.08 (-0.99%)
FB   288.02 (+0.51%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,209.37 (-0.33%)
TSLA   561.14 (-4.04%)
NVDA   542.20 (+1.23%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.43 (+2.01%)
AMD   93.86 (+1.33%)
T   28.94 (+0.24%)
NIO   46.52 (+2.56%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.75 (-0.36%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.42 (+1.99%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   123.03 (+0.25%)
MSFT   214.08 (-0.99%)
FB   288.02 (+0.51%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,209.37 (-0.33%)
TSLA   561.14 (-4.04%)
NVDA   542.20 (+1.23%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.36 (+2.07%)
MU   68.43 (+2.01%)
AMD   93.86 (+1.33%)
T   28.94 (+0.24%)
NIO   46.52 (+2.56%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.75 (-0.36%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.42 (+1.99%)
Log in
ASX:IDT

IDT Australia Limited (IDT.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. The company offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services, as well as pharmaceutical development services in all dosage forms. Its services also include project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs. In addition, the company offers medical cannabis products; and various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.33 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolASX:IDT
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.idtaus.com.au
Phone61 3 9801 8888
EmployeesN/A

Debt

Debt-to-Equity Ratio0.02
Current Ratio2.59
Quick Ratio2.32

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$14.17 million
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.10 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

Receive IDT News and Ratings via Email

Sign-up to receive the latest news and ratings for IDT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











IDT Australia Limited (IDT.AX) (ASX:IDT) Frequently Asked Questions

What stocks does MarketBeat like better than IDT Australia Limited (IDT.AX)?

Wall Street analysts have given IDT Australia Limited (IDT.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but IDT Australia Limited (IDT.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of IDT Australia Limited (IDT.AX)'s key competitors?

Some companies that are related to IDT Australia Limited (IDT.AX) include (CSI) (CSI), (IMCC) (IMCC), 1933 Industries (TGIFF), 28896 (BAMM), AB Science (ABSCF), Abattis Bioceuticals (ATT), Acreage (ACRDF), AFT Pharmaceuticals Limited (AFP.AX) (AFP), Agraflora Organics International (AGRA), AgraFlora Organics International (AGFAF), Aleafia Health (ALEAF), American Green (ERBB), Australian Primary Hemp Limited (APH.AX) (APH), Benitec Biopharma (BLT) and Better Plant Sciences (BOSQF).
View all competitors.

Who are IDT Australia Limited (IDT.AX)'s key executives?

IDT Australia Limited (IDT.AX)'s management team includes the following people:
  • Dr. David Sparling L.L.B., BVSc (Hons), GDipAppCGov, LLB (Hons), CEO & Joint Company Sec.
  • Ms. Ancila Desai, CFO & Joint Company Sec.
  • Mr. Jim Sosic, VP of Operations, Supply & Infrastructure
  • Mr. Daniel Broadhurst, Head of Quality

What is IDT Australia Limited (IDT.AX)'s stock symbol?

IDT Australia Limited (IDT.AX) trades on the ASX under the ticker symbol "IDT."

How big of a company is IDT Australia Limited (IDT.AX)?

IDT Australia Limited (IDT.AX) has a market capitalization of $0.00 and generates $14.17 million in revenue each year.

What is IDT Australia Limited (IDT.AX)'s official website?

The official website for IDT Australia Limited (IDT.AX) is www.idtaus.com.au.

How can I contact IDT Australia Limited (IDT.AX)?

The company can be reached via phone at 61 3 9801 8888.

This page was last updated on 12/2/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.